Estrogen

Estrogen has been studied in 558 papers since 1980: 13 trials and 105 observational studies in people, 70 in animals, 5 in cells, 355 reviews; 196 in the past year. The newest paper, Nov 16, 2026: “Hormonal Therapy for Osteoporosis: Mechanisms, Trial Evidence, and Current Place in Fracture Prevention”.

Intervention

558 papers study it3,134 more mention it398 findingsUpdated

PubChemChEBIMeSH

Research on it is growing 42% faster than aging research as a whole: 145 papers in the latest year counted

194 new papers in 30 daysSee all 3,690 papers on estrogen

At a glance

Mouse studies report lower oxidative stress with estrogen, reproduced by independent labs; one study reports improved muscle calcium entry in aging male mice. A human cohort links oral estrogen alone during menopause with higher dementia risk, while human mortality associations point both ways. Some papers declare ties to companies including Bayer.

398 findings in 283 papers from 1985 to 2026, 62 of them since April 2026

Independent labs found the same change in mice and people. 122 independent labs in 34 countries; 45 trials, 6 about aging, 21 with no results posted.

“Among participants with a history of migraine, randomization to E-only MHT was not associated with more severe headache at 1 year (adjusted odds ratio [aOR] = 1.14, 95% confidence interval [CI]: 0.90-1.44)”
Menopausal hormone therapy, migraine history, and headache severity: Results from the Women's Health Initiative Hormone Therapy clinical trialsHeadache2026doi:10.1111/head.70168

12 of its findings point the other way.

Mice and humans: replicated by independent labs. Cells: a single group. Worms or flies: nothing yet.
  • 122 independent labs in 34 countries
  • 12 findings against
  • 45 trials, 6 about aging, 21 with no results posted
  • Funders: National Institutes of Health and others
  • 20 of 214 findings with company ties
  • 2 of 45 trials sponsored by its developers
  • Human trial13
  • Humans104
  • Animals70
  • Cells5
  • In silico4

6 studies gave estrogen to people and measured what changed.

What changedDesignPeopleSource

no change: Has no effect on headache severityaOR 1.14, 95% CI 0.90-1.44

Randomized trial1 year22,876 peopleWomenaverage age 64 yearsOlder adults; Postmenopausal women; in participants with a history of migraineHeadache, Jul 8, 2026

no change: Has no effect on plasma Alzheimer's biomarker

Randomized trialaverage 15-year follow-upWomenPostmenopausal women; postmenopausal womenMaturitas, Feb 11, 2026

down: Decreases cervical dysplasia>90% resolution

Trial4–6 months800 peopleWomenaged 40 and olderMidlife adults; Older adults; Postmenopausal women; Patient cohortsENDO 2025 abstract, Oct 22, 2025

down: Decreases genitourinary syndrome of menopause

Trial4 monthsWomenpostmenopausalPostmenopausal women; postmenopausal women with at least one moderate-to-severe GSM complaintMedicina (Kaunas, Lithuania), Dec 30, 2023

up: Improves recognition memory

down: Impairs perceptual identification

Randomized trial4 weeks6 peopleWomenPostmenopausal womenHormones and behavior, Feb 1, 2004

What did studies of estrogen find?

215

Studies of estrogen measured 215 outcomes; the most studied are genitourinary syndrome of menopause (8 studies), apoptosis (7) and cardiovascular disease (6).

Genitourinary syndrome of menopause

downin humans8

8 studies
  1. Estrogen decreases genitourinary syndrome of menopause in humans (postmenopausal women with at least one moderate-to-severe GSM complaint).

    “CO2L, RF, and ET significantly improved GSM concerning the vulvar vestibule at the 4 months follow-up.”

    Human trialpostmenopausal women with at least one moderate-to-severe GSM complaintvulvar vestibule4 monthsfemales

    Fractional CO₂ Laser, Radiofrequency and Topical Estrogen for Treating Genitourinary Syndrome of Menopause: A Pilot Study Evaluating the Vulvar Vestibule

    Medicina (Kaunas, Lithuania)

  2. Estrogen decreases genitourinary syndrome of menopause in genitourinary syndrome of menopause.

    “Local estrogen remains supported by a comparatively mature evidence base, whereas energy-based and regenerative strategies show biological and clinical signals but greater heterogeneity and uncertainty.”

    Reviewin genitourinary syndrome of menopauselocal

    Beyond Vaginal Atrophy: A Systematic Review of the Multidimensional Pathophysiology, Phenotypes, and Personalized Management of Genitourinary Syndrome of Menopause

    International Journal of Research Publications

  3. Estrogen decreases genitourinary syndrome of menopause in humans (for genitourinary syndrome of menopause in patients with cancer).

    “Vaginal estrogen is effective for genitourinary syndrome of menopause, is appropriate in most gynecologic cancers”

    Reviewfor genitourinary syndrome of menopause in patients with cancervaginal

    Menopause Management in Patients With Cancer

    Obstetrics and gynecology

  4. Estrogen decreases genitourinary syndrome of menopause in humans.

    “Hormonal therapies – local estrogen, ospemifene, and intravaginal dehydroepiandrosterone (DHEA) – partially restore prevalence and reduce symptom burden”

    Review

    Vaginal Microbiome in Perimenopause and Postmenopause: Dysbiosis, Genitourinary Syndrome and Novel Therapeutic Approaches

    Obstetrics and gynecology.

  5. Estrogen decreases genitourinary syndrome of menopause in survivors of hormone-sensitive cancer with genitourinary syndrome of menopause.

    “low-dose vaginal estrogen provides significant symptom relief and efficacy in easing genitourinary symptoms and reducing urinary tract infections with minimal systemic absorption.”

    Reviewin survivors of hormone-sensitive cancer with genitourinary syndrome of menopauselow-dose vaginalfemales

    Genitourinary syndrome of menopause in women with cancer - a narrative review

    Maturitas

  6. Estrogen decreases genitourinary syndrome of menopause in humans (moderate to severe genitourinary syndrome of menopause).

    “For moderate to severe GSM, low-dose vaginal estrogen, vaginal DHEA, and ospemifene are all effective FDA-approved options.”

    Reviewmoderate to severe genitourinary syndrome of menopause

    Case-Based Perspectives on the Management of Genitourinary Syndrome of Menopause

    Clinics and practice

  7. Estrogen decreases genitourinary syndrome of menopause in humans.

    “While there are various treatment options, the most effective one is low-dose topical estrogen therapy.”

    Reviewtopicallow-dosefemales

    Genitourinary Syndrome of Menopause: A Narrative Review Focusing on Its Effects on the Sexual Health and Quality of Life of Women

    Cureus

  8. Estrogen decreases genitourinary syndrome of menopause in humans (postmenopausal women).

    “The prescription options have proven efficacy and safety”

    Reviewpostmenopausal womenfemales

    Genitourinary Syndrome of Menopause

    Journal of midwifery & women's health

More on Genitourinary syndrome of menopause

Apoptosis

downin reviews4downin humans1downin mice1downin mouse cells1+1

7 studies
  1. Estrogen inhibits apoptosis.

    “reducing the production of reactive oxygen species in the electron transport chain, inhibiting apoptosis, and regulating mitochondrial DNA content”

    Review

    Estrogen receptors in mitochondrial metabolism: age-related changes and implications for pregnancy complications

    Aging advances

  2. Estrogen decreases apoptosis in mouse cells (D-gal-treated cells).

    “Estrogen and the AQP4 inhibitor TGN020 both reduced the apoptosis rate and AQP4 expression.”

    CellsD-gal-treated cellsprimary spiral ganglion cell

    Estrogen inhibits the apoptosis of spiral ganglion cells in C57BL/6J mice with presbycusis by downregulating AQP4

    Preprint

  3. Estrogen inhibits apoptosis in mice (ovariectomized C57BL/6J mice).

    “Estrogen inhibited apoptosis of cochlear spiral ganglion cells in aged C57BL/6J mice by downregulating AQP4”

    Animalsovariectomized C57BL/6J micecochlear spiral ganglion cell1 or 2 months

    Estrogen inhibits the apoptosis of spiral ganglion cells in C57BL/6J mice with presbycusis by downregulating AQP4

    Preprint

  4. Estrogen decreases apoptosis.

    “oestrogen can effectively alleviate IVDD development by inhibiting the apoptosis of IVD cells”

    Reviewintervertebral disc cell

    Intervertebral disc ageing and degeneration: The antiapoptotic effect of oestrogen

    Ageing research reviews

  5. Estrogen prevents apoptosis in humans (estrogen deficiency).

    “Evidence is accumulating that estrogen deficiency induces apoptosis in skeletal muscle contributing to loss of mass and thus strength.”

    Reviewestrogen deficiencyskeletal musclefemales

    Aging of the musculoskeletal system: How the loss of estrogen impacts muscle strength

    Bone

  6. Estrogen prevents apoptosis.

    “Basic studies have demonstrated that estrogen treatment prevents apoptosis and necrosis of cardiac and endothelial cells.”

    Review

    Estrogen and the cardiovascular system

    Pharmacology & therapeutics

  7. Estrogen induces apoptosis in cells with wild-type ERalpha.

    “a polymeric form of estrogen that is not capable of stimulating the nuclear-initiated actions of ERalpha was as effective as 17beta-estradiol in inducing osteoclast apoptosis”

    Cellsin cells with wild-type ERalpha

    The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone

    Molecular endocrinology (Baltimore, Md.)

  8. Estrogen inhibits apoptosis.

    “gonadotropins, estrogens, growth hormone, growth factors (IGFI, EGF/TGF-alpha, basic FGF), cytokine (interleukin-1 beta) and nitric oxide act in concert to ensure the survival of preovulatory follicles”

    Reviewovary

    Gonadal cell apoptosis

    Recent progress in hormone research

More on Apoptosis

Cardiovascular disease

downin humans5downin reviews1

6 studies
  1. Estrogen protects against cardiovascular disease in humans (initiated before the age of 60).

    “demonstrated the protective role of estrogen in cardiovascular disease (CVD) and bone health, particularly when initiated before the age of 60.”

    Reviewinitiated before the age of 60

    Management of menopausal hormone therapy

    Current opinion in obstetrics & gynecology

  2. Estrogen protects against cardiovascular disease in humans.

    “Estrogen confers cardioprotective effects via nitric oxide (NO)-mediated vasodilation and antioxidant pathways.”

    Review

    Endothelial Dysfunction in Sex-Specific Disparities in Cardiovascular Diseases: Biological Mechanisms, Diagnostic-Therapeutic Differences, and Translational Medicine Strategies

    Reviews in cardiovascular medicine

  3. Estrogen protects against cardiovascular disease in humans.

    “Estrogen provides a protective effect against heart disease in women.”

    Reviewfemales

    Menopause and women's cardiovascular health: is it really an obvious relationship?

    Archives of medical science : AMS

  4. Estrogen protects against cardiovascular disease in humans (before menopause).

    “The vasculoprotective role of estrogens are well established before menopause, but the consequences of their abrupt decline on the cardiovascular risk at menopause remain debated.”

    Reviewbefore menopause

    Estrogen Receptor and Vascular Aging

    Frontiers in aging

  5. Estrogen protects against cardiovascular disease.

    “Most of these studies suggested that endogenous estrogen confers cardiovascular protective and anti-inflammatory effects.”

    Review

    Signalling mechanisms in the cardiovascular protective effects of estrogen: With a focus on rapid/membrane signalling

    Current research in physiology

  6. Estrogen protects against cardiovascular disease in humans.

    “Premenopausal women have a lower incidence of cardiovascular disease, which may partly be due to a protective effect of estrogen on endothelial function”

    Reviewfemales

    Relationship Between Endothelial Function and the Eliciting Shear Stress Stimulus in Women: Changes Across the Lifespan Differ to Men

    Journal of the American Heart Association

More on Cardiovascular disease

Inflammation

downin humans2downin rats2downin mice1upin reviews1

6 studies
  1. Estrogen decreases inflammation in rats (through ER).

    “Estrogen replacement therapy appears to alleviate depressive-like behaviors by reducing brain inflammation and supporting the brain's adaptive capacities through ER.”

    Animalsthrough ERbrainfemales

    Estrogen Replacement Therapy in Ovariectomized Rats: Complementary Roles of ER and GPR30 in Alleviating Depressive-like Behavior

    Current issues in molecular biology

  2. Estrogen decreases inflammation in ovariectomized and lead-exposed rats.

    “The observed biochemical and histological perturbations were attenuated by HRT.”

    Animalsin ovariectomized and lead-exposed ratsprefrontal cortex28 daysfemalesn = 30

    Estrogen replacement therapy reverses spatial memory loss and pyramidal cell neurodegeneration in the prefrontal cortex of lead-exposed ovariectomized Wistar rats

    Current research in toxicology

  3. Estrogen decreases inflammation in humans (postmenopausal women).

    “Estrogen prevents dementia by augmenting Hippocampal and prefrontal cortex function, reducing neuroinflammation”

    Reviewpostmenopausal womenbrainfemales

    The Role of Estrogen Therapy as a Protective Factor for Alzheimer's Disease and Dementia in Postmenopausal Women: A Comprehensive Review of the Literature

    Cureus

  4. Estrogen inhibits inflammation in ovariectomized aged mice.

    “VET reverses age-associated upregulation of inflammatory genes and pathways”

    Animalsin ovariectomized aged micebladderfemales

    Supraphysiologic Vaginal Estrogen Therapy in Aged Mice Mitigates Age-Associated Bladder Inflammatory Response to Urinary Tract Infections

    Urogynecology (Philadelphia, Pa.)

  5. Estrogen decreases inflammation in humans.

    “Estrogens have a protective effect on skeletal muscle by attenuating inflammation;”

    Reviewskeletal muscle

    Sex Differences in Muscle Wasting

    Advances in experimental medicine and biology

  6. Estrogen increases inflammation in some settings.

    “in some settings estrogen can have pro-inflammatory effects.”

    Reviewin some settings

    The effects of estrogen in ischemic stroke

    Translational stroke research

More on Inflammation

Oxidative stress and ROS signaling

downin mice2downin humans1downin mouse cells1downin rats1+1

6 studies
  1. Estrogen decreases oxidative stress and ROS signaling in mice (aging).

    “treatment with estrogen (a) significantly reduced the formation of TAs; (b) reduced oxidative stress”

    Animalsagingdrinking waterskeletal musclemales

    Estrogens and Antioxidants Prevent the Formation of Tubular Aggregates in Aging Male Mice

    International journal of molecular sciences

  2. Estrogen decreases oxidative stress and ROS signaling.

    “In the mitochondria, estrogen functions by reducing the production of reactive oxygen species in the electron transport chain”

    Review

    Estrogen receptors in mitochondrial metabolism: age-related changes and implications for pregnancy complications

    Aging advances

  3. Estrogen decreases oxidative stress and ROS signaling in ovariectomized and lead-exposed rats.

    “The observed biochemical and histological perturbations were attenuated by HRT.”

    Animalsin ovariectomized and lead-exposed ratsprefrontal cortex28 daysfemalesn = 30

    Estrogen replacement therapy reverses spatial memory loss and pyramidal cell neurodegeneration in the prefrontal cortex of lead-exposed ovariectomized Wistar rats

    Current research in toxicology

  4. Estrogen protects against oxidative stress and ROS signaling in humans.

    “age-related estrogen deficiency, taking into account their antioxidant properties, is considered as one of the triggers for this condition development”

    Review

    Age-related menopause and carbonyl stress

    Advances in gerontology = Uspekhi gerontologii

  5. Estrogen decreases oxidative stress and ROS signaling in mouse cells (LPS-induced in bEnd.3 brain endothelial cells).

    “the lipopolysaccharide (10 ng/mL)-induced increases of hepcidin mRNA and protein levels, the number of Prussian blue-positive cells, and free radicals were reduced after estrogen treatment”

    CellsLPS-induced in bEnd.3 brain endothelial cellsbrain endothelial cells

    Estrogen deficiency is associated with brain iron deposition via upregulation of hepcidin expression in aged female mice

    Neurobiology of aging

  6. Estrogen decreases oxidative stress and ROS signaling in mice (gonadectomy).

    “Exactly the same changes in oxidative stress were acutely reproduced by gonadectomy in 5-month-old females or males and reversed by estrogens or androgens in vivo as well as in vitro.”

    Animalsgonadectomy

    Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids

    The Journal of biological chemistry

More on Oxidative stress and ROS signaling

Cellular senescence

no changein human cells1downin humans1downin mice1downin rat cells1+1

5 studies
  1. Estrogen decreases cellular senescence in pelvic floor connective tissue.

    “mitigation of cellular senescence”

    Reviewin pelvic floor connective tissue

    Multidimensional regulation of estrogen signaling in pelvic floor connective tissue homeostasis and remodeling

    Frontiers in immunology

  2. Estrogen prevents cellular senescence in male mice on a ketogenic diet.

    “the increases in p53, p21, cellular senescence, MnSOD acetylation, and oxidative stress in male mice on a KD were all prevented by estrogen treatment”

    Animalsin male mice on a ketogenic dietmales

    Divergent sex-specific effects on a ketogenic diet: Male, but not female, mice exhibit oxidative stress and cellular senescence

    Cell reports

  3. Estrogen showed no clear effect on cellular senescence in human cells (HRASG12V expression).

    “We experimentally confirmed the inability of HRASG12V-expressing EnSCs to bypass senescence and resume proliferation, even upon estrogen stimulation.”

    CellsHRASG12V expressionendometrial stroma

    Oncogene-Induced Senescence Is a Crucial Antitumor Defense Mechanism of Human Endometrial Stromal Cells

    International journal of molecular sciences

  4. Estrogen inhibits cellular senescence.

    “estrogen protects against genotoxic insult and inhibits senescence regulatory proteins”

    Review

    Evidence of sex differences in cellular senescence

    Neurobiology of aging

  5. Estrogen decreases cellular senescence in BMSCs from OVX rats.

    “BMSCs from the OVX rats displayed increased senescence and weaker SATB2 expression, stemness, and osteogenic differentiation, while estrogen could rescue these phenotypes.”

    Cellsin BMSCs from OVX rats

    Estrogen regulates stemness and senescence of bone marrow stromal cells to prevent osteoporosis via ERβ-SATB2 pathway

    Journal of cellular physiology

More on Cellular senescence

Cognitive function

upin mice2upin humans1upin reviews1

4 studies
  1. Estrogen is linked with better cognitive function in humans (non-depressed older women) (effect size = .61, p = .02).

    “Within the non-depressed participants, higher CLEE was associated with improved delayed recall”

    Humansnon-depressed older womenfemalesn = 71

    The Effect of Cumulative Lifetime Estrogen Exposure on Cognition in Depressed Versus Non-Depressed Older Women

    Journal of geriatric psychiatry and neurology

  2. Estrogen improves cognitive function.

    “Estrogen was found to enhance synaptic plasticity, dendritic spine density, neurogenesis, and hippocampal-dependent cognition through genomic and non-genomic mechanisms.”

    Review

    The interplay between sex hormones and brain plasticity across the lifespan

    The Egyptian Journal of Internal Medicine

  3. Estrogen improves cognitive function in mice (sevoflurane-exposed C57BL/6 mice).

    “increasing synaptic vesicle density and neuronal firing frequency, and improving cognitive function.”

    Animalssevoflurane-exposed C57BL/6 micefemales

    Estrogen improves sevoflurane-induced cognitive dysfunction by regulating synaptic zinc homeostasis

    Molecular medicine (Cambridge, Mass.)

  4. Estrogen improves cognitive function in mice after surgery and anesthesia.

    “their cognitive function improved after estrogens supplementation (P < 0.05).”

    Animalsafter surgery and anesthesiamales

    Hippocampal estrogens rescued the decline of synaptic plasticity after surgery and anesthesia by inhibiting microglia overactivation

    Behavioural brain research

Bone loss

downin humans1downin mice1downin rats1

3 studies
  1. Estrogen decreases bone loss in ovariectomized rats.

    “Estrogen treatment markedly alleviated OVX-induced bone loss”

    Animalsin ovariectomized rats

    Estrogen Suppresses Osteoclast Function and Cytoskeletal Remodeling via Modulation of the RhoA-Pkn3-c-Src Signaling Pathway in Ovariectomized Rats

    Biology

  2. Estrogen decreases bone loss in mice (postmenopausal osteoporosis).

    “The delivery system significantly reduced bone loss in postmenopausal osteoporotic mice”

    Animalspostmenopausal osteoporosisCA-PEOz drug delivery systembone

    Citric acid-modified pH-sensitive bone-targeted delivery of estrogen for the treatment of postmenopausal osteoporosis

    Materials today. Bio

  3. Estrogen prevents bone loss in women at high risk for osteoporosis.

    “For women at high risk for osteoporosis, especially perimenopausal women with low bone density and other risk factors, estrogen or other therapies are available to prevent bone loss.”

    Reviewin women at high risk for osteoporosis

    Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society

    Menopause (New York, N.Y.)

Breast cancer

no changein humans3

3 studies
  1. Estrogen was not clearly linked with breast cancer in prior pre-eclamptic women.

    “whereas estrogen only was not associated with BC risk in prior pre-eclamptic women.”

    Humansin prior pre-eclamptic women

    Reduced Breast Cancer Risk in Women With A History of Pre-Eclampsia: Implications of Postmenopausal Hormone Therapy

    The Journal of clinical endocrinology and metabolism

  2. Estrogen was not clearly linked with breast cancer in humans (past long-term use of oestrogen only therapy).

    “Past long term use of oestrogen only therapy and past short term (<5 years) use of oestrogen-progestogen were not associated with increased risk.”

    Humanspast long-term use of oestrogen only therapyoestrogen only therapylong-term usefemalesn = 457,498

    Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases

    BMJ (Clinical research ed.)

  3. Estrogen showed no clear effect on breast cancer in humans after hysterectomy.

    “estrogen-alone therapy after hysterectomy does not increase breast cancer incidence”

    Reviewafter hysterectomy

    Menopausal hormone therapy and breast cancer: risk and management

    Current opinion in obstetrics & gynecology

More on Breast cancer

Mortality

downin humans2no changein humans1HR 0.99

3 studies
  1. Estrogen was not clearly linked with mortality in humans (estrogen-only users compared with non-users, matched on age and general practice) (HR 0.99 (95% CI 0.93-1.07)).

    “estrogen-only formulation was not associated with any significant changes”

    Humansestrogen-only users compared with non-users, matched on age and general practiceestrogen-onlyfemales

    The effect of hormone replacement therapy on the survival of UK women: a retrospective cohort study 1984-2017

    BJOG : an international journal of obstetrics and gynaecology

  2. Estrogen decreases mortality in humans after hysterectomy.

    “estrogen-alone therapy after hysterectomy does not increase breast cancer incidence and is associated with reduced mortality”

    Reviewafter hysterectomy

    Menopausal hormone therapy and breast cancer: risk and management

    Current opinion in obstetrics & gynecology

  3. Estrogen decreases mortality in humans (early initiation in younger menopausal women).

    “consistently show reductions in coronary heart disease and mortality in younger menopausal women.”

    Reviewearly initiation in younger menopausal womenfemales

    Estrogen rapid effects: a window of opportunity for the aging brain?

    Neural regeneration research

Headache severity

no changein humans1

1 study
  1. Estrogen showed no clear effect on headache severity in participants with a history of migraine (aOR 1.14, 95% CI 0.90-1.44).

    “Among participants with a history of migraine, randomization to E-only MHT was not associated with more severe headache at 1 year (adjusted odds ratio [aOR] = 1.14, 95% confidence interval [CI]: 0.90-1.44)”

    Human trialin participants with a history of migraineoral1 yearfemales

    Combined hormone therapy linked to worsening headaches

    Headache

Plasma Alzheimer's biomarker

no changein humans1

1 study
  1. Estrogen showed no clear effect on plasma Alzheimer's biomarker in humans (postmenopausal women; compared with placebo).

    “did not significantly differ for estrogen alone vs placebo or estrogen plus progestin vs placebo.”

    Human trialpostmenopausal women; compared with placeboplasmaaverage 15-year follow-upfemales

    Randomization to hormone therapy and changes in plasma biomarkers of Alzheimer's pathology: The women's health initiative memory study

    Maturitas

More on Plasma Alzheimer's biomarker

Cervical dysplasia

downin humans1

1 study
  1. Estrogen decreases cervical dysplasia in humans (>90% resolution).

    “Over 90% of participants experienced resolution of abnormal cytology within 4–6 months of initiating local estrogen therapy.”

    Human triallocal vaginalcervix4–6 monthsfemalesn = 800

    SUN-103 False Positive Cervical Dysplasia As One Of The Earliest Signs Of Genitourinary Syndrome Of Menopause

    ENDO 2025 abstract

More on Cervical dysplasia

Sexual function

upin humans1

1 study
  1. Estrogen improves sexual function in humans (Postmenopausal women; compared with licorice vaginal cream) (Sexual function scores: estrogen 17.14 ± 3.99 to 22.97 ± 5.09; licorice 17.86 ± 4.37 to 20.31 ± 4.63).

    “The effect of estrogen vaginal cream on the sexual function of postmenopausal women was greater than licorice vaginal cream.”

    Human trialPostmenopausal women; compared with licorice vaginal creamvaginal cream2%2 months follow-upfemalesn = 82

    Comparison of the effect of licorice vaginal cream and estrogen vaginal cream on sexual function of postmenopausal women: An RCT

    International journal of reproductive biomedicine

Perceptual identification

downin humans1

1 study
  1. Estrogen impairs perceptual identification in humans.

    “This pattern reversed in perceptual identification with estrogens producing a negative effect and androgens producing a positive effect.”

    Human trialfemalesn = 6

    Evidence that androgenic and estrogenic metabolites contribute to the effects of dehydroepiandrosterone on cognition in postmenopausal women

    Hormones and behavior

All 215

What is estrogen linked with?

98

Studies link estrogen with 98 measures, most often breast cancer (8 studies), venous thromboembolism (5) and Alzheimer's disease (5).

Breast cancer

downin humans4upin humans4RR 0.77

8 studies
  1. Estrogen is linked with a higher risk of breast cancer in humans (adjusting for BMI and menopausal status) (aOR 1.33, 95% CI 1.13-1.57).

    “each standard deviation increase in CLEEE was associated with 33% higher BC odds (aOR 1.33, 95% CI 1.13-1.57)”

    Humansadjusting for BMI and menopausal status

    Association of cumulative lifetime estrogen exposure and reproductive factors with breast cancer molecular subtype among Nigerian women in the MEND study

    Breast cancer research and treatment

  2. Estrogen is linked with a lower risk of breast cancer in BRCA1 or BRCA2 carriers, compared with unexposed matched controls (HR 0.37, 95% CI 0.24 to 0.57).

    “women who used estrogen alone experienced a statistically significantly decreased risk of breast cancer (hazard ratio = 0.37, 95% CI = 0.24 to 0.57)”

    Humansin BRCA1 or BRCA2 carriers, compared with unexposed matched controlsfemalesn = 676

    Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in BRCA1 or BRCA2

    Journal of the National Cancer Institute

  3. Estrogen is linked with a higher risk of breast cancer in humans (postmenopausal).

    “In postmenopausal women, higher estrogens and androgens were associated with an increase in breast cancer risk, whereas higher SHBG was inversely associated with risk.”

    Humanspostmenopausalfemales

    Linking Physical Activity to Breast Cancer via Sex Steroid Hormones, Part 2: The Effect of Sex Steroid Hormones on Breast Cancer Risk

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

  4. Estrogen is linked with a higher risk of breast cancer in humans (recent (<5 years) use with long-term use (≥5 years), compared with never use) (adjusted odds ratio 1.15 (95% CI 1.09 to 1.21)).

    “oestrogen only therapy and combined oestrogen and progestogen therapy were both associated with increased risks of breast cancer”

    Humansrecent (<5 years) use with long-term use (≥5 years), compared with never useoestrogen only therapylong-term use (≥5 years)femalesn = 457,498

    Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases

    BMJ (Clinical research ed.)

  5. Estrogen lowers the risk of breast cancer in patients who have undergone hysterectomy at population risk for breast cancer (3.6% vs 4.7% (RR 0.77, 95% CI 0.65-0.91)).

    “relative risk 0.77; 95% CI, 0.65-0.91, P=.002”

    Reviewin patients who have undergone hysterectomy at population risk for breast cancer

    Menopausal Estrogen Therapy and Risk of Breast Cancer

    Obstetrics and gynecology

  6. Estrogen raises the risk of breast cancer in observational studies.

    “Estrogen-only therapy (ET) shows a modest risk increase in observational studies, but RCT data (e.g., WHI) suggest reduced incidence and mortality.”

    Reviewin observational studies

    MENOPAUSAL HORMONE THERAPY AND BREAST CANCER RISK

    International Journal of Innovative Technologies in Social Science

  7. Estrogen lowers the risk of breast cancer in menopause.

    “estrogen-alone therapy has been linked to reductions in both breast cancer incidence and mortality.”

    Reviewin menopause

    Menopausal hormone therapy and breast cancer: Balancing risks and benefits

    Maturitas

  8. Estrogen is associated with breast cancer in humans.

    “Oestrogen only therapy in women who have undergone hysterectomy appears associated with a lower risk of breast cancer than combined oestrogen and progestogen MHT.”

    Reviewwomen who have undergone hysterectomy; compared with combined estrogen and progestogen menopausal hormone treatmentfemales

    Menopausal hormone treatment and breast cancer

    The lancet. Diabetes & endocrinology

More on Breast cancer

Venous thromboembolism

upin humans5HR 1.62

5 studies
  1. Estrogen is associated with venous thromboembolism in humans (British-South Asian women).

    “VTE prevalence increased with obesity, hypertension, dyslipidemia, chronic kidney disease, estrogen use, and in the presence of FVL.”

    HumansBritish-South Asian womenfemalesn = 20,048

    Factor V Leiden, estrogen, and multimorbidity association with venous thromboembolism in a British-South Asian cohort

    iScience

  2. Estrogen raises the risk of venous thromboembolism in humans (hepatic first-pass metabolism).

    “oral estrogens undergo hepatic first-pass metabolism, elevating venous thromboembolism risk”

    Reviewhepatic first-pass metabolismoralfemales

    Menopausal Hormone Therapy and Cardiovascular Risk: Current Evidence and Treatment Recommendations

    Cardiology in review

  3. Estrogen raises the risk of venous thromboembolism in humans (HR 1.62, 95% CI 1.41–1.86).

    “Venous thromboembolism risk was significantly elevated with oral estrogen (HR 1.62; 95% CI 1.41–1.86)”

    Revieworalfemales

    Cardiovascular and Cancer Risks Associated with Different Hormone Replacement Therapy Regimens: A Systematic Review and Meta-Analysis (2020–2025 Evidence)

    Journal of medical & health sciences review.

  4. Estrogen raises the risk of venous thromboembolism in humans.

    “Clinical guidelines recognise oral oestrogen as a VTE risk factor”

    Revieworal

    Perioperative hormone replacement therapy (HRT) and venous thromboembolism risk: a scoping review of available evidence and guidance

    JRSM open

  5. Estrogen raises the risk of venous thromboembolism in humans.

    “Exogenous estrogen, commonly in the form of combined hormonal contraceptives and menopausal hormone therapies, is associated with changes in coagulation proteins leading to increased risk of venous thromboembolism (VTE).”

    Reviewcombined hormonal contraceptives and menopausal hormone therapies

    Women's and Transgender Issues in Thrombosis and Hemostasis: Laboratory Parameters of Coagulation and Fibrinolysis Influenced by Hormones, Including Pregnancy and Postpartum

    Clinics in laboratory medicine

More on Venous thromboembolism

Alzheimer's disease

downin humans4upin humans1HR 1.081

5 studies
  1. Estrogen is linked with a higher risk of Alzheimer's disease in humans during menopause (HR 1.081, 95% CI 1.03–1.134).

    “TIB (HR 1.041, 95% confidence interval (CI) 1.01-1.072) and oral estrogen alone (HR 1.081, 95% CI 1.03-1.134) were associated with a higher risk of AD dementia.”

    Humansduring menopauseoral estrogen alonefemales

    Menopausal hormone therapy and risk of dementia: health insurance database in South Korea-based retrospective cohort study

    Frontiers in aging neuroscience

  2. Estrogen lowers the risk of Alzheimer's disease in humans.

    “Research shows that a longer reproductive lifespan, or a greater cumulative estrogen exposure, is associated with slower cognitive decline and reduced AD risk.”

    Reviewfemales

    Reproductive Lifespan as a Proxy for Estrogen Exposure and Alzheimer’s Disease Risk in Women: A Multisystem Perspective

    International journal of high school research

  3. Estrogen lowers the risk of Alzheimer's disease in humans (initiated within ~five years of menopause).

    “oral estrogen-only therapy initiated within ~five years of menopause is most consistently associated with reduced AD risk”

    Reviewinitiated within ~five years of menopauseoral

    Testing the Critical Window Hypothesis in Alzheimer’s Disease: brain vs gut mechanisms of estrogen therapy timing

    Journal of High School Science

  4. Estrogen lowers the risk of Alzheimer's disease in postmenopausal women.

    “Estrogen reduces the risk of AD in postmenopausal women.”

    Reviewin postmenopausal womenfemales

    The preventive role of tempeh isoflavones on menopausal women's cognitive function: A multiple mechanism pathway

    Journal of Alzheimer's disease reports

  5. Estrogen lowers the risk of Alzheimer's disease in brain imaging studies.

    “In contrast, brain imaging studies provide encouraging evidence for positive associations between greater cumulative lifetime estrogen exposure and lower AD risk in women”

    Reviewin brain imaging studiesfemales

    Endogenous and Exogenous Estrogen Exposures: How Women's Reproductive Health Can Drive Brain Aging and Inform Alzheimer's Prevention

    Frontiers in aging neuroscience

More on Alzheimer's disease

Cardiovascular disease

downin humans4

4 studies
  1. Estrogen lowers the risk of cardiovascular disease in humans.

    “Exposure to endogenous oestrogen during the reproductive years provides women with protection against cardiovascular disease”

    Reviewfemales

    Menopause: a cardiometabolic transition

    The lancet. Diabetes & endocrinology

  2. Estrogen is associated with cardiovascular disease in humans.

    “incidence of cardiovascular disease in postmenopausal women is significantly higher than that in men”

    Reviewcardiovascular systemfemales

    Protective Effects of Estrogen on Cardiovascular Disease Mediated by Oxidative Stress

    Oxidative medicine and cellular longevity

  3. Estrogen lowers the risk of cardiovascular disease in humans.

    “its many beneficial effects on cardiovascular health are lost whereby the age-related risk of cardiovascular disease is accelerated”

    Reviewfemales

    The exercise timing hypothesis: can exercise training compensate for the reduction in blood vessel function after menopause if timed right?

    The Journal of physiology

  4. Estrogen lowers the risk of cardiovascular disease in humans.

    “suggests that estrogens play a protective role against cardiovascular disease and that this role is also modified by ageing”

    Reviewfemales

    Role of miRNA in the Regulatory Mechanisms of Estrogens in Cardiovascular Ageing

    Oxidative medicine and cellular longevity

More on Cardiovascular disease

Coronary artery disease

downin humans3RR 0.78

3 studies
  1. Estrogen lowers the risk of coronary artery disease in humans (Initiation within 10 years of menopause; versus placebo) (RR 0.78; 95% CI 0.66-0.92).

    “estrogen alone reduced coronary heart disease (CHD) risk (RR 0.78; 95% CI 0.66-0.92)”

    ReviewInitiation within 10 years of menopause; versus placebofemales

    Cardiometabolic Effects of Menopause Hormone Therapy in Women with or at Risk for Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    AHA Scientific Sessions 2026 abstract

  2. Estrogen is associated with coronary artery disease in humans (compared with nonuse).

    “Vaginal estrogen use is associated with lower risk for coronary heart disease (CHD)”

    Reviewcompared with nonusevaginal

    Does vaginal estrogen use increase the risk for adverse cardiovascular outcomes?

    The Journal of family practice

  3. Estrogen lowers the risk of coronary artery disease in humans (early initiation in younger menopausal women).

    “consistently show reductions in coronary heart disease and mortality in younger menopausal women.”

    Reviewearly initiation in younger menopausal womenfemales

    Estrogen rapid effects: a window of opportunity for the aging brain?

    Neural regeneration research

More on Coronary artery disease

Migraine

upin humans2downin humans1

3 studies
  1. Estrogen is associated with migraine in humans (early perimenopause, with anovulatory cycles).

    “Hyperestrogenism during early perimenopause, coupled with anovulatory cycles, is associated with an increased frequency and severity of migraine attacks”

    Reviewearly perimenopause, with anovulatory cyclesfemales

    Perimenopausal migraine: a narrative review

    Climacteric : the journal of the International Menopause Society

  2. Estrogen is associated with migraine in humans (reproductive lifespan).

    “Its occurrence and clinical expression are closely associated with hormonal fluctuations throughout the reproductive lifespan, particularly those involving estrogen.”

    Reviewreproductive lifespanfemales

    Migraine across the menopausal transition: a scoping review

    Preprint

  3. Estrogen is associated with migraine in humans.

    “In women, migraine remissions are associated with stable and critical oestrogen levels.”

    Reviewfemales

    Menopause hormone therapy, migraines, and thromboembolism

    Best practice & research. Clinical obstetrics & gynaecology

More on Migraine

Mortality

upin humans2downin humans1OR 0.2–0.4

3 studies
  1. Estrogen is linked with a lower risk of mortality in women with recurrent urinary tract infection (OR 0.2-0.4 across age groups).

    “Mortality increased with age in both groups but remained lower among estrogen recipients at 0.3%-3.9% vs 0.8%-9.6% in nonrecipients (OR 0.2-0.4 across age groups).”

    Humansin women with recurrent urinary tract infectionfemales

    Vaginal Estrogen Prescription is Associated with Reduced Risk of Serious Adverse Outcomes in Women of All Age Groups with Recurrent Urinary Tract Infection: An Epic Cosmos Database Analysis

    Urology

  2. Estrogen is associated with mortality in humans (before accounting for discontinuation) (aHR 4.73, 1.22 to 18.32).

    “Use of systemic estrogens alone is associated with increased COVID-19 mortality among older women (aHR 4.73, 1.22 to 18.32)”

    Humansbefore accounting for discontinuationfemales

    Estrogen-modulating treatment among mid-life women and COVID-19 morbidity and mortality: a multiregister nationwide matched cohort study in Sweden

    BMC medicine

  3. Estrogen is linked with a higher risk of mortality in humans (HR, 1.02; 95% CI 1.00-1.04).

    “unopposed cumulative E exposure (HR, 1.02; 95% CI 1.00-1.04) were significantly harmful for all-cause mortality.”

    Humansfemales

    Fertile lifespan characteristics and all-cause and cause-specific mortality among postmenopausal women: the Rotterdam Study

    Fertility and sterility

Cognitive function

mixedin humans1upin humans1mixedin reviews1

3 studies
  1. Estrogen is associated with cognitive function in humans.

    “evidence for shared genetic architecture between lifetime estrogen exposure and AD-related cognitive decline”

    Humansn = 33,918

    Sex-Specific Genetic Drivers of Memory, Executive Functioning, and Language Performance in Older Adults

    medRxiv : the preprint server for health sciencesPreprint

  2. Estrogen is associated with cognitive function in humans.

    “oestrogen directly impacted performance”

    Humansn = 121

    Reaping the hormonal rewards: investigating the role of sex hormones and cognitive performance in healthy older adults

    Research SquarePreprint

  3. Estrogen is associated with cognitive function.

    “estrogen modulates cognition in animal models”

    Reviewfemales

    Socially Housed Female Macaques: a Translational Model for the Interaction of Chronic Stress and Estrogen in Aging

    Current psychiatry reports

Glaucoma

downin humans1upin humans1OR 1.33

2 studies
  1. Estrogen is linked with a lower risk of glaucoma in humans (P < 0.001).

    “long-term estrogen use (n = 39 202) showed decreased risk of glaucoma diagnosis (P < 0.001).”

    Humanslong-termn = 39,202

    Association of glaucoma diagnosis with sex hormone-related diagnoses and hormone-replacement therapy within a national U.S. database

    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie

  2. Estrogen is linked with a higher risk of glaucoma in humans (adjusted OR, 1.33 [95% CI, 1.17-1.52]).

    “The risk was found in estrogen users (adjusted OR, 1.33 [95% CI, 1.17-1.52])”

    Humansfemales

    Hormonal replacement therapy in postmenopausal women ≥50 years is associated with the incidence of glaucoma: Evidence from 6576 females in Finland

    Acta ophthalmologica

More on Glaucoma

Osteoporotic fractures

downin humans1upin humans1

2 studies
  1. Estrogen lowers the risk of osteoporotic fractures in postmenopausal women.

    “estrogens reduce the risk of osteoporotic-related fractures, including hip and vertebral and nonvertebral fractures, in postmenopausal women.”

    Reviewin postmenopausal womenestrogensfemales

    Efficacy and safety of estrogen therapy for prevention of osteoporosis in postmenopausal women

    Women's health (London, England)

  2. Estrogen is associated with osteoporotic fractures in postmenopausal women.

    “estrogen use and vitamin D supplements were significantly associated with osteoporotic fracture in postmenopausal women.”

    Reviewin postmenopausal women

    Predictors of osteoporotic fracture in postmenopausal women: a meta-analysis

    Journal of orthopaedic surgery and research

More on Osteoporotic fractures

All 98

What acts on estrogen?

1

Studies name Parvalbumin-positive interneuron as acting on estrogen.

Parvalbumin-positive interneuron

upin humans1

1 study
  1. parvalbumin-positive interneuron increases estrogen in humans.

    “Parvalbumin-positive (PV) interneurons enhance synaptic activity-dependent brain-derived estradiol (BDE2) synthesis in a sex-specific manner”

    Reviewbrain

    Menopausal insomnia as a modifiable node of dementia risk: Mechanistic insights and intervention strategies

    Alzheimer's & dementia : the journal of the Alzheimer's Association

Has estrogen been tested in people?

6 of 45 about aging

Yes: 13 trials and 105 observational studies in people have been published, and 43 trials are registered.

Every condition in trials

40 of 50

Stopped

  • NCT00203996TerminatedObstructive sleep apnea

    Did not meet target patient accrual goals

Trial sponsors

Funding

142 grants since 2016

National Institute on Aging$62MNational Institute of Diabetes and Digestive and Kidney Diseases$23.8MNational Heart, Lung, and Blood Institute$21.2M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Estrogen reduces oxidative stress in mice in studies from independent labs; one study also reports improved store-operated calcium entry in aging male mouse muscle. Human studies link estrogen with higher breast cancer risk after menopause but lower risk in BRCA1/2 carriers; mortality associations point both ways. Some papers disclose company ties.

  2. Summary rewritten as its findings changed.

    As it read before

    Estrogen reduces oxidative stress in mice, a result reproduced by independent labs; a preprint reports protection against age-related hearing loss in ovariectomized mice. Independent labs also link estrogen use with higher breast cancer risk in women, whereas a study links it with lower risk in BRCA1 or BRCA2 carriers. Some papers declare company ties.

  3. Summary rewritten as its findings changed.

    As it read before

    Estrogen reduces senescence in rat cells and oxidative stress in mice across independent labs; human cohorts link use with higher breast cancer risk in postmenopausal women but lower risk in BRCA1/2 carriers. Four registered trials concern aging; across uses, 21 ended over a year ago without posted results. Some authors have company affiliations; two trials have company sponsors.

  4. Summary rewritten as its findings changed.

    As it read before

    One rat study shows that estrogen reduces bone loss and improves trabecular bone microarchitecture in ovariectomized rats. A human preprint associates vaginal estrogen use for at least six weeks with urinary lactobacilli in postmenopausal women.

  5. Summary written from the findings.

Latest

See all 3,690 papers on estrogen